{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:35Z","timestamp":1787020955640,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":688,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1186\/s13613-024-01388-x","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:02:42Z","timestamp":1729080162000},"page":"157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Biomarkers in cardiogenic shock: old pals, new friends"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-4065","authenticated-orcid":false,"given":"Mathieu","family":"Jozwiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1186\/s13613-024-01388-x_bb0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014a position statement from the heart failure association of the European society of cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","article-title":"Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States","volume":"107","author":"Shah","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13613-024-01260-y","article-title":"Management of cardiogenic shock: a narrative review","volume":"14","author":"Laghlam","year":"2024","journal-title":"Ann Intensiv Care"},{"key":"10.1186\/s13613-024-01388-x_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123192","article-title":"Lactate: the fallacy of oversimplification","author":"Muller","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13054-016-1403-5","article-title":"The value of blood lactate kinetics in critically ill patients: a systematic review","volume":"20","author":"Vincent","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00134-018-5475-3","article-title":"Prognostic relevance of serum lactate kinetics in critically ill patients","volume":"45","author":"Masyuk","year":"2019","journal-title":"Intensiv Care Med"},{"issue":"5","key":"10.1186\/s13613-024-01388-x_bb0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00134-024-07385-9","article-title":"Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial","volume":"50","author":"Ahlstedt","year":"2024","journal-title":"Intensiv Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-024-01266-6","article-title":"Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study","volume":"14","author":"Levy","year":"2024","journal-title":"Ann Intensiv Care"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0055","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cardfail.2021.08.012","article-title":"Lactate clearance is associated with improved survival in cardiogenic shock: a systematic review and meta-analysis of prognostic factor studies","volume":"27","author":"Marbach","year":"2021","journal-title":"J Card Fail"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12872-020-01785-7","article-title":"Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study","volume":"20","author":"Scolari","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"19","key":"10.1186\/s13613-024-01388-x_bb0065","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jcin.2020.06.037","article-title":"Arterial lactate in cardiogenic shock: prognostic value of clearance versus single values","volume":"13","author":"Fuernau","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1186\/s13613-024-01388-x_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28\u00a0day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hernandez","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1186\/s13613-024-01388-x_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1186\/s13613-024-01388-x_bb0080","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Poss","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1186\/s13613-024-01388-x_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2015.04.242","article-title":"Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"191","author":"Fuernau","year":"2015","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1186\/s13613-024-01388-x_bb0090","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2017.06.049","article-title":"Frequency and prognostic significance of abnormal liver function tests in patients with cardiogenic shock","volume":"120","author":"Jantti","year":"2017","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12872-021-01903-z","article-title":"Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1186\/s13613-024-01388-x_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14050503","article-title":"Clinical interpretation of serum troponin in the era of high-sensitivity testing","author":"Maayah","year":"2024","journal-title":"Diagnostics"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/hrt.2010.195511","article-title":"Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the global registry of acute coronary events","volume":"97","author":"Jolly","year":"2011","journal-title":"Heart"},{"issue":"17","key":"10.1186\/s13613-024-01388-x_bb0110","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.292.17.2096","article-title":"Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative","volume":"292","author":"Bhatt","year":"2004","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01388-x_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.1147","article-title":"Troponin in cardiogenic shock not caused by acute myocardial infarction, a predictor of mortality","author":"Beer","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1186\/s13613-024-01388-x_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13091348","article-title":"Cardiac troponin I but notn-TERMINAL pro-B-type natriuretic peptide predicts outcomes in cardiogenic shock","author":"Schupp","year":"2023","journal-title":"J Pers Med"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/CCM.0000000000000107","article-title":"Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*","volume":"42","author":"Landesberg","year":"2014","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjmed.2010.06.021","article-title":"Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease","volume":"123","author":"Vasile","year":"2010","journal-title":"Am J Med"},{"issue":"9","key":"10.1186\/s13613-024-01388-x_bb0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clinbiochem.2017.02.007","article-title":"Clearance of cardiac troponin T with and without kidney function","volume":"50","author":"Friden","year":"2017","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/0391398821991155","article-title":"Peak troponin predicts successful weaning from VA ECMO in patients with acute myocardial infarction complicated by cardiogenic shock","volume":"45","author":"North","year":"2022","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1186\/s13613-024-01388-x_bb0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"9380","key":"10.1186\/s13613-024-01388-x_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0155","first-page":"392","article-title":"An outlook on biomarkers in cardiogenic shock","volume":"26","author":"Iborra-Egea","year":"2020","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ahj.2009.11.001","volume":"159","author":"Jarai","year":"2010","journal-title":"Am Heart J"},{"issue":"17","key":"10.1186\/s13613-024-01388-x_bb0165","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/eurheartj\/ehi260","article-title":"High plasma n-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock","volume":"26","author":"Verges","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0170","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc4839","article-title":"Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study","volume":"10","author":"Januzzi","year":"2006","journal-title":"Crit Care"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1399-6576.2006.00963.x","article-title":"B-type natriuretic peptide (BNP) and n-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress","volume":"50","author":"Bal","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1378\/chest.128.1.288","article-title":"Utility of B-type natriuretic peptide and n-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients","volume":"128","author":"Jefic","year":"2005","journal-title":"Chest"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0185","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1515\/CCLM.2008.294","article-title":"What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care?","volume":"46","author":"Christenson","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1186\/s13613-024-01388-x_bb0190","first-page":"377","article-title":"Cardiovascular biomarkers in the ICU","volume":"15","author":"Noveanu","year":"2009","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SHK.0b013e31818635b6","article-title":"Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population","volume":"31","author":"Kotanidou","year":"2009","journal-title":"Shock"},{"issue":"6","key":"10.1186\/s13613-024-01388-x_bb0200","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/CCM.0b013e31819fe896","article-title":"Early assessment of outcome in cardiogenic shock: relevance of plasma n-terminal pro-B-type natriuretic peptide and interleukin-6 levels","volume":"37","author":"Jarai","year":"2009","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1432-1327.1999.00615.x","article-title":"Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells","volume":"264","author":"Iwahana","year":"1999","journal-title":"Eur J Biochem"},{"issue":"6","key":"10.1186\/s13613-024-01388-x_bb0210","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"issue":"23","key":"10.1186\/s13613-024-01388-x_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027618","article-title":"Circulating biomarkers in hypertrophic cardiomyopathy","volume":"11","author":"Matthia","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1186\/s13613-024-01388-x_bb0220","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2018.08.2165","article-title":"sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T","volume":"72","author":"Emdin","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1186\/s13613-024-01388-x_bb0225","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0230","first-page":"205","article-title":"Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality","volume":"17","author":"Parenica","year":"2012","journal-title":"Exp Clin Cardiol"},{"issue":"7","key":"10.1186\/s13613-024-01388-x_bb0235","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1097\/CCM.0000000000002336","article-title":"Combined measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide provides early assessment of severity in cardiogenic shock complicating acute coronary syndrome","volume":"45","author":"Tolppanen","year":"2017","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-024-01388-x_bb0240","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jointm.2022.05.001","article-title":"Alternatives to norepinephrine in septic shock: which agents and when?","volume":"2","author":"Jozwiak","year":"2022","journal-title":"J Intensiv Med"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0255","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br J Anaesth"},{"issue":"38","key":"10.1186\/s13613-024-01388-x_bb0260","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","article-title":"Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13054-024-04875-6","article-title":"Vascular leak in sepsis: physiological basis and potential therapeutic advances","volume":"28","author":"McMullan","year":"2024","journal-title":"Crit Care"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0275","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.CIR.97.11.1062","article-title":"Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide","volume":"97","author":"Szokodi","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0280","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/cc13731","article-title":"Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis","volume":"18","author":"Marino","year":"2014","journal-title":"Crit Care"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0285","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-009-1610-5","article-title":"Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients","volume":"35","author":"Guignant","year":"2009","journal-title":"Intensiv Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-016-1361-y","article-title":"Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients","volume":"20","author":"Lundberg","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13613-016-0229-2","article-title":"Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock","volume":"7","author":"Tolppanen","year":"2017","journal-title":"Ann Intensiv Care"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/000331970505600105","article-title":"Relationship between adrenomedullin and left-ventricular systolic function and mortality in acute myocardial infarction","volume":"56","author":"Katayama","year":"2005","journal-title":"Angiology"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0305","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","article-title":"Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial","volume":"47","author":"Laterre","year":"2021","journal-title":"Intensiv Care Med"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0310","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(21)00439-2","article-title":"Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial","volume":"10","author":"Karakas","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1186\/s13613-024-01388-x_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","author":"Akwii","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0320","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/cc9020","article-title":"Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity","volume":"14","author":"Davis","year":"2010","journal-title":"Crit Care"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13054-021-03474-z","article-title":"Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure","volume":"25","author":"Yu","year":"2021","journal-title":"Crit Care"},{"issue":"11","key":"10.1186\/s13613-024-01388-x_bb0330","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ejhf.342","article-title":"Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock\u2013a biomarker substudy of the IABP-SHOCK II-Trial","volume":"17","author":"Poss","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0335","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1097\/CCM.0000000000000524","article-title":"Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis","volume":"42","author":"Stiehl","year":"2014","journal-title":"Crit Care Med"},{"issue":"6163","key":"10.1186\/s13613-024-01388-x_bb0340","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"issue":"24","key":"10.1186\/s13613-024-01388-x_bb0345","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1073\/pnas.85.24.9797","article-title":"Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor","volume":"85","author":"de Nucci","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1186\/s13613-024-01388-x_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13132277","article-title":"Could endothelin-1 be a promising neurohormonal biomarker in acute heart failure?","author":"Dmour","year":"2023","journal-title":"Diagnostics"},{"issue":"6","key":"10.1186\/s13613-024-01388-x_bb0355","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ejhf.766","article-title":"Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure","volume":"19","author":"Demissei","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0360","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.456","article-title":"Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy","volume":"18","author":"Perez","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0365","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0735-1097(95)00520-X","article-title":"Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure","volume":"27","author":"Pacher","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0375","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13054-023-04752-8","article-title":"Extending the 'host response' paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities","volume":"27","author":"Buckel","year":"2023","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0380","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjcard.2007.09.088","article-title":"Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction","volume":"101","author":"Smit","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1186\/s13613-024-01388-x_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2020.08.069","article-title":"Kinetics of procalcitonin, c-reactive protein and interleukin-6 in cardiogenic shock\u2014insights from the CardShock study","volume":"322","author":"Kataja","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1186\/s13613-024-01388-x_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030965","article-title":"C-reactive protein and white blood cell count in cardiogenic shock","author":"Dudda","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1186\/s13613-024-01388-x_bb0395","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/SHK.0000000000001876","article-title":"Leukocyte and its subtypes as predictors of short-term outcome in cardiogenic shock complicating acute myocardial infarction: a cohort study","volume":"57","author":"Sasmita","year":"2022","journal-title":"Shock"},{"key":"10.1186\/s13613-024-01388-x_bb0400","article-title":"Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit","author":"Patel","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"39","key":"10.1186\/s13613-024-01388-x_bb0405","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1093\/eurheartj\/ehz783","article-title":"Molecular signature of cardiogenic shock","volume":"41","author":"Iborra-Egea","year":"2020","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0410","first-page":"731","article-title":"Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock","volume":"11","author":"Hongisto","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1186\/s13613-024-01388-x_bb0415","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-023-02366-2","article-title":"GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudy","author":"Lehrke","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1186\/s13613-024-01388-x_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713111","article-title":"The role of galectin-3 in heart failure-the diagnostic, prognostic and therapeutic potential-where do we stand?","author":"Zaborska","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10.1186\/s13613-024-01388-x_bb0425","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/eurheartj\/ehz294","article-title":"Protein-based cardiogenic shock patient classifier","volume":"40","author":"Rueda","year":"2019","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1186\/s13613-024-01388-x_bb0430","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/ejhf.2588","article-title":"Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock","volume":"24","author":"Scolari","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"10410","key":"10.1186\/s13613-024-01388-x_bb0435","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","article-title":"Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials","volume":"402","author":"Zeymer","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0440","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jchf.2023.06.024","article-title":"Precision medicine in cardiogenic shock: we are almost there!","volume":"11","author":"Mebazaa","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"14","key":"10.1186\/s13613-024-01388-x_bb0445","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1186\/s13613-024-01388-x_bb0450","first-page":"1006","article-title":"Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population","volume":"99","author":"Jentzer","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0455","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0460","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12872-023-03380-y","article-title":"Identification of distinct clinical phenotypes of cardiogenic shock using machine learning consensus clustering approach","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1186\/s13613-024-01388-x_bb0465","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ehf2.14596","article-title":"Clinical phenotypes of cardiogenic shock survivors: insights into late host responses and long-term outcomes","volume":"11","author":"Soussi","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1186\/s13613-024-01388-x_bb0470","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1164\/rccm.202204-0687OC","article-title":"Performance of early capillary refill time measurement on outcomes in cardiogenic shock: an observational, prospective multicentric study","volume":"206","author":"Merdji","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0475","first-page":"29","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1186\/s13613-024-01388-x_bb0480","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13054-022-04249-w","article-title":"Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review","volume":"26","author":"Charbonneau","year":"2022","journal-title":"Crit Care"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-024-01388-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:44:54Z","timestamp":1776671094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025003048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2110582025003048"],"URL":"https:\/\/doi.org\/10.1186\/s13613-024-01388-x","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in cardiogenic shock: old pals, new friends","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-024-01388-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 The Author(s) 2024. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"157"}}